
Sign up to save your podcasts
Or
Could this finally be a big shake up in the price of insulin? Civica Rx plans to sell the most popular types of fast and long acting insulin for a flat price of 30-dollars a vial. This week you'll hear from Ned McCoy, Civica’s Chief Operating Officer. He explains why they’re confident this will work, who will be able to buy the finished product, when it will be available and what Civica RX is all about.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Check out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! -----
Episode Transcription Below (or coming soon!)
Please visit our Sponsors & Partners - they help make the show possible!
*Click here to learn more about AFREZZA* *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM*4.7
210210 ratings
Could this finally be a big shake up in the price of insulin? Civica Rx plans to sell the most popular types of fast and long acting insulin for a flat price of 30-dollars a vial. This week you'll hear from Ned McCoy, Civica’s Chief Operating Officer. He explains why they’re confident this will work, who will be able to buy the finished product, when it will be available and what Civica RX is all about.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Check out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! -----
Episode Transcription Below (or coming soon!)
Please visit our Sponsors & Partners - they help make the show possible!
*Click here to learn more about AFREZZA* *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM*108 Listeners
2,398 Listeners
1,588 Listeners
3,446 Listeners
3,364 Listeners
643 Listeners
4,305 Listeners
9,362 Listeners
64 Listeners
2,010 Listeners
117 Listeners
131 Listeners
10 Listeners
41 Listeners
10 Listeners